Biofilm formation, multidrug-resistance and clinical infections of Staphylococcus haemolyticus: A brief review
DOI:
https://doi.org/10.33448/rsd-v11i11.33605Keywords:
Staphylococcus haemolyticus; Multidrug-resistance; Biofilm; Pathogenicity; Medical device-related infection.Abstract
Coagulase-negative staphylococci (CoNS) have been associated with a range of human health issues such as medical device-related infection, localized skin infection, or direct infection, are recognized as comprising the main part of human normal microbiota and associated with severe and intensive infections, causing infections in humans, especially immunocompromised patients and neonates. S. haemolyticus is, after Staphylococcus epidermidis, the second most frequently isolated CoNS from clinical cases, notably from blood infections, including sepsis. The most important factor might be the ability to acquire multiresistance against available antimicrobial agents, even glycopeptides. It is widespread in hospitals and among medical staff, resulting in being an emerging microbe causing nosocomial infections. This review discuss aspects of S. haemolyticus bloodstream infections associated, virulence factors, and the ability of biofilm formation on medical devices surfaces. The great adaptability and the ability to survive in the hospital environment, especially on medical devices, S. haemolyticus becomes a crucial factor in nosocomial infections caused by multiresistant strains.
References
Ahmed, A., et al. (2019). Catheter related recurrent bloodstream infection caused by linezolid-resistant, methicillin resistant Staphylococcus haemolyticus; an emerging super bug. J Pak Med Assoc; 69(2):261–263.
Al-TamimiM., Abu-RaidehJ., Himsawi N., Khasawneh A., Hawamdeh H. (2020). Methicillin and vancomycin resistance in coagulase-negative Staphylococci isolated from the nostrils of hospitalized patients. J Infect Dev Ctries; 14:28-35.
Argemi, X., et al. (2019). Coagulase-Negative Staphylococci Pathogenomics. Int J Mol Sci; 20(5):1215.
Aronson, J.K., Heneghan, C., Ferner, R.E. (2020). Medical Devices: Definition, Classification, and Regulatory Implications. Drug Saf; 43(2):83-93.
Asaad, A.M., Ansar, Q.M., Mujeeb, H.S. (2016). Clinical significance of coagulase-negative staphylococci isolates from nosocomial bloodstream infections. Infect Dis (Lond);48(5):356-60.
Asante J., et al. (2020). Review of Clinically and Epidemiologically Relevant Coagulase-Negative Staphylococci in Africa. Microbial Drug Resistance; 26(8):951-970.
Barros EM., Ceotto H., Bastos MC., Santos KR., Giambiagi-Demarval M. (2012). Staphylococcus haemolyticus as an important hospital pathogen and carrier of methicillin resistance genes. J. Clin. Microbiol; 50, 166–168.
Bakthavatchalam, Y.D., et al. (2017). Methicillin-Susceptible Teicoplanin-Resistant Staphylococcus haemolyticus Isolate from a Bloodstream Infection with Novel Mutations in the tcaRAB Teicoplanin Resistance Operon. Jpn J Infect Dis; 24;70(4):458-460.
Bakthavatchalam, Y.D., et al. (2021). Vancomycin heteroresistance in Staphylococcus haemolyticus: elusive phenotype. Future Sci OA; 9;7(7): FSO710.
Becker, K., Heilmann, C., Peters, G. (2014). Coagulase-negative staphylococci. Clin Microbiol Rev; 27(4):870-926.
Bouchami, O., Achour, W., Hassen, A.B. (2011). Species distribution and antibiotic sensitivity pattern of coagulase-negative Staphylococci other than Staphylococcus epidermidis isolated from various clinical specimens. Afr. J. Microbiol; 5:1298–1305.
Cavanagh, J.P., et al. (2014). Whole-genome sequencing reveals clonal expansion of multiresistant Staphylococcus haemolyticus in European hospitals. J Antimicrob Chemother; 69(11):2920–7.
Chandra, J., Kuhn, DM., Mukherjee, PK., Hoyer, LL., McCormick, T., Ghannoum, MA. (2001). Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 183(18):5385-94.
Costerton, J., Montanaro, L., Arciola, C. (2005). Biofilm in implant infections: its production and regulation. Int J Artif Organs; 28:1062–1068.
Czekaj, T., Ciszewski, M., Szewczyk, E.M. (2015). Staphylococcus haemolyticus – an emerging threat in the twilight of the antibiotics age. Microbiology; 161(11):2061–2068.
Eltwisy, H.O., et al. (2020). Pathogenesis of Staphylococcus haemolyticus on primary human skin fibroblast cells. Virulence; 11(1):1142-1157.
Feßler, A.T., et al. (2017). Complete sequence of a plasmid from a bovine methicillin-resistant Staphylococcus aureus harbouring a novel ica-like gene cluster in addition to antimicrobial and heavy metal resistance genes. Vet Microbiol; 200: 95-100.
Gupta, V., et al. (2020). Linezolid Resistance in Staphylococcus haemolyticus - Case Series and Review of Literature. Infect Disord Drug Targets; 20(5):713-717.
Heilmann, C., Ziebuhr, W., Becker, K. (2019). Are coagulase-negative staphylococci virulent? Clin Microbiol Infect; 25(9):1071-80.
Hessam, S., et al. (2016). Microbial Profile and Antimicrobial Susceptibility of Bacteria Found in Inflammatory Hidradenitis Suppurativa Lesions. Skin Pharmacol Physiol; 29(3):161-7.
Horasan, E.S., et al. (2011). Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients. Med Sci Monit; 17:CR304-9.
Kim, H.J., Jang, S. (2017). Draft genome sequence of multidrug-resistant Staphylococcus haemolyticus IPK_TSA25 harbouring a Staphylococcus aureus plasmid, pS0385-1. J Glob Antimicrob Resist; 11:8-9.
Lamers, R.P., et al. (2012). Phylogenetic relationships among Staphylococcus species and refinement of cluster groups based on multilocus data. BMC Evol. Biol; 12:171.
Lee, E.Y., et al. (2017). What is hidradenitis suppurativa? Can Fam Physician; 63(2):114-120.
Manoharan A., Das T., Whiteley GS., Glasbey T., Kriel FH., Manos J. (2020). The effect of N-acetylcysteine in a combined antibiofilm treatment against antibiotic-resistant Staphylococcus aureus. J Antimicrob Chemother; 1;75(7):1787-1798.
Mores, C.R., et al. (2021). Investigation of Plasmids Among Clinical Staphylococcus aureus and Staphylococcus haemolyticus Isolates from Egypt. Front Microbiol; 12:659116.
Natsis, N.E., Cohen, P.R. (2018). Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections. Am J Clin Dermatol; 19(5):671-677.
O’Neill, J. (2016). Tackling drug-resistant infections globally: final report and recommendations. Londres. https://amrreview.org/sites/default/files/160525_Final%20paper_with%20cover.pdf. Accessed 10 Feb 2021.
Pain, M., et al. (2019). Comparative Genomic Analysis of Staphylococcus haemolyticus Reveals Key to Hospital Adaptation and Pathogenicity. Front Microbiol; 10; 10:2096.
Pais-Correia, AM., Sachse, M., Guadagnini, S. et al. (2010). Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat Med ;16: 83–89.
Pereira, P.M., et al. (2014). Staphylococcus haemolyticus disseminated among neonates with bacteremia in a neonatal intensive care unit in Rio de Janeiro, Brazil. Diagn Microbiol Infect Dis; 78(1):85-92.
Pereira-Ribeiro, P.M., et al. (2019). Influence of antibiotics on biofilm formation by different clones of nosocomial Staphylococcus haemolyticus. Future Microbiol; 14:789-799.
Pereira-Ribeiro, P.M., et al. (2022). Biofilm-producing ability of Staphylococcus spp. multridrug-resistance isolated from hospitalized patients with osteomyelitis. IJSRM Human; 20(4):147-161.
Rodríguez-Aranda, A., et al. (2009). Nosocomial spread of linezolid-resistant Staphylococcus haemolyticus infections in an intensive care unit. Diagn Microbiol Infect Dis; 63(4):398-402.
Rogers, K.L., Fey, P.D., Rupp, M.E. (2009). Coagulase-negative staphylococcal infections. Infect Dis Clin North Am; 23(1):73-98.
Savage, V.J., Chopra, I., O’Neill, A.J. (2013). Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob Agents Chemother; 57:1968–1970.
Schilcher, K., Horswill, A. R. (2020). Staphylococcal biofilm development: structure, regulation and treatment strategies. Microbiol Mol Biol Rev; 12;84(3): e00026-19.
Silva, P.V., et al. (2013). The antimicrobial susceptibility, biofilm formation and genotypic profiles of Staphylococcus haemolyticus from bloodstream infections. Mem Inst Oswaldo Cruz; 108 (6):812–813.
Silva-Santana, G., et al. (2021). Staphylococcus aureus biofilms: an opportunistic pathogen with multidrug resistance. R Med Microbiol; 32(1):12-21.
Sued, B.P.R., et al. (2017). Sphygmomanometers and thermometers as potential fomites of Staphylococcus haemolyticus: biofilm formation in the presence of antibiotics. Mem Inst Oswaldo Cruz; 112(3):188-195.
Sued-Karam, B.R., Pereira-Ribeiro, P.M.A. (2022). Staphylococcus warneri: brief literature review. Braz J Health Review; 5(2):4423-4429.
Szabo, J. (2009). hVISA/VISA: diagnostic and therapeutic problems. Expert Rev Anti Infect Ther; 7(1), 1–3.
Takeuchi, F., et al. (2005). Whole-genome sequencing of Staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing staphylococcal species. J Bacteriol; 187(21):7292-308.
Tuchscherr, L., et al. (2010). Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis; 202:1031e40.
Vanderhaeghen, W., et al. (2014). Invited review: effect, persistence, and virulence of coagulase-negative Staphylococcus species associated with ruminant udder health. J Dairy Sci; 97:5275–5293.
Veach, L.A., et al. (1990). Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol; 28(9):2064-8.
Yong, Y.Y., Dykes, G.A., Choo, W.S. (2019). Biofilm formation by staphylococci in health-related environments and recent reports on their control using natural compounds. Crit Rev Microbiol; 45(2):201-222.
Wolden, R., Pain, M., Karlsson, R. et al. Identification of surface proteins in a clinical Staphylococcus haemolyticus isolate by bacterial surface shaving. (2020). BMC Microbiol; 20:80.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Paula Marcele Afonso Pereira-Ribeiro; Guilherme Goulart Cabral-Oliveira; Julianna Giordano Botelho Olivella; Isabelle Christine de Moraes Motta; Felipe Caldas Ribeiro; Barbara Araújo Nogueira; Louisy Sanches dos Santos; Bruna Ribeiro Sued-Karam; Ana Luíza Mattos-Guaraldi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
